Cooley advised Tools For Humanity on the financing. Tools for Humanity, the technology company behind Worldcoin, announced that it has raised $115 million in series C...
You must be a Standard 1 Year member to access this content.
Cooley advised QED Investors on the fundraising. QED Investors announced the closing of two new funds with combined capital commitments of $925 million. The new capital...
You must be a Standard 1 Year member to access this content.
Cooley is acting as legal counsel to Veritone, and Sidley Austin is acting as legal counsel to Career Builder. Veritone, Inc. (NASDAQ: VERI) announced its agreement...
You must be a Standard 1 Year member to access this content.
Cooley advised Neo on the fundraising. Neo announced the closing of two funds totaling $235 million. Neo will invest $180 million in seed deals and accelerator...
You must be a Standard 1 Year member to access this content.
Cooley advised Plymouth Growth on the fundraising. Plymouth Growth announced its closing of Plymouth Growth V, LP, with approximately $125 million in committed capital. Plymouth Fund...
You must be a Standard 1 Year member to access this content.
Cooley advised m]x[v Capital on the fundraising. m]x[v Capital announced the closing of its $52 million debut fund. Proceeds from the debut fund will be used to...
You must be a Standard 1 Year member to access this content.
Cooley and Pinsent Masons acted as legal advisers to Toluna. Toluna announced it has entered an agreement to acquire MetrixLab from Macromill, Inc. With a closing...
You must be a Standard 1 Year member to access this content.
Cooley advised Zai Lab on the deal. Zai Lab, a research-based commercial-stage biopharmaceutical company, announced its strategic partnership and exclusive worldwide license agreement with MediLink Therapeutics, as...
You must be a Standard 1 Year member to access this content.
Cooley advised NeuExcell Therapeutics on the deal. NeuExcell Therapeutics, a neurodegenerative disease gene therapy company, announced its $15 million+ Series Pre-A+ financing round. Investors in the round...
You must be a Standard 1 Year member to access this content.
Cooley advised Zion Pharma Limited on the deal. Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, announced the acquisition of its...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Davis Polk represented the underwriters, Cooley represented Arlo and its officers and directors, and Wilson Sonsini represented Netgear. In the California state and federal court securities...
You must be a Standard 1 Year member to access this content.
